Virtus ETF Advisers’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,029
| Closed | -$61.7K | – | 387 |
|
2024
Q4 | $61.7K | Sell |
3,029
-1,135
| -27% | -$23.1K | 0.03% | 440 |
|
2024
Q3 | $121K | Buy |
4,164
+72
| +2% | +$2.1K | 0.06% | 351 |
|
2024
Q2 | $95K | Buy |
4,092
+357
| +10% | +$8.29K | 0.05% | 336 |
|
2024
Q1 | $76.6K | Sell |
3,735
-259
| -6% | -$5.32K | 0.04% | 398 |
|
2023
Q4 | $85.7K | Buy |
3,994
+949
| +31% | +$20.4K | 0.05% | 414 |
|
2023
Q3 | $62.8K | Sell |
3,045
-304
| -9% | -$6.27K | 0.04% | 401 |
|
2023
Q2 | $98.8K | Buy |
3,349
+56
| +2% | +$1.65K | 0.06% | 388 |
|
2023
Q1 | $75.9K | Sell |
3,293
-1,259
| -28% | -$29K | 0.04% | 392 |
|
2022
Q4 | $127K | Sell |
4,552
-323
| -7% | -$8.98K | 0.07% | 400 |
|
2022
Q3 | $150K | Buy |
4,875
+36
| +0.7% | +$1.11K | 0.06% | 354 |
|
2022
Q2 | $142K | Buy |
4,839
+1,406
| +41% | +$41.3K | 0.05% | 326 |
|
2022
Q1 | $110K | Sell |
3,433
-200
| -6% | -$6.41K | 0.05% | 287 |
|
2021
Q4 | $162K | Buy |
3,633
+803
| +28% | +$35.8K | 0.06% | 320 |
|
2021
Q3 | $143K | Sell |
2,830
-150
| -5% | -$7.58K | 0.06% | 349 |
|
2021
Q2 | $234K | Sell |
2,980
-664
| -18% | -$52.1K | 0.1% | 231 |
|
2021
Q1 | $208K | Buy |
3,644
+58
| +2% | +$3.31K | 0.09% | 322 |
|
2020
Q4 | $300K | Sell |
3,586
-8,878
| -71% | -$743K | 0.12% | 211 |
|
2020
Q3 | $447K | Sell |
12,464
-1,710
| -12% | -$61.3K | 0.23% | 147 |
|
2020
Q2 | $343K | Sell |
14,174
-4,846
| -25% | -$117K | 0.16% | 272 |
|
2020
Q1 | $333K | Sell |
19,020
-2,785
| -13% | -$48.8K | 0.14% | 216 |
|
2019
Q4 | $380K | Buy |
21,805
+8,311
| +62% | +$145K | 0.06% | 275 |
|
2019
Q3 | $207K | Sell |
13,494
-752
| -5% | -$11.5K | 0.04% | 242 |
|
2019
Q2 | $296K | Buy |
14,246
+1,045
| +8% | +$21.7K | 0.06% | 223 |
|
2019
Q1 | $307K | Sell |
13,201
-1,589
| -11% | -$37K | 0.65% | 59 |
|
2018
Q4 | $306K | Sell |
14,790
-10,928
| -42% | -$226K | 0.05% | 107 |
|
2018
Q3 | $559K | Sell |
25,718
-18,899
| -42% | -$411K | 0.06% | 108 |
|
2018
Q2 | $680K | Buy |
+44,617
| New | +$680K | 0.6% | 107 |
|